Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POTE ankyrin domain family member B3 (POTEB3) is a human protein-coding gene belonging to the POTE ankyrin domain family, which is characterized by the presence of ankyrin repeats and shared sequence features across paralogs[2][9]. POTEB3 is primarily named for its expression in the prostate, ovary, and testis, and is located on chromosome 15[8]. Its precise biological functions remain unclear, but family members are generally thought to have roles in cellular scaffolding or protein-protein interactions[4]. POTEB3 has been associated in some genomic studies with childhood kidney cell carcinoma, though direct mechanistic or therapeutic significance is unestablished[2]. There are currently no known drugs, confirmed receptor activity, or widely recognized biomarker or safety concerns related to POTEB3, and it is not currently considered a classical therapeutic target such as a receptor, enzyme, or transporter[2][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POTE ankyrin domain family member B3 (POTEB3).